Xeris Biopharma Holdings, Inc. (XERS)
6.225
+0.30
(+5.15%)
USD |
NASDAQ |
May 20, 16:00
6.225
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Profit Margin (Quarterly) : 2.69% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Zoetis, Inc. | 26.57% |
| Harrow, Inc. | -62.44% |
| Corcept Therapeutics, Inc. | -18.92% |
| Assertio Holdings, Inc. | -189.8% |
| Johnson & Johnson | 21.75% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 3.33% |
| Return on Invested Capital | 4.72% |
| Gross Profit Margin (Quarterly) | 84.02% |
| Operating Margin (Quarterly) | 9.52% |
| Return on Net Operating Assets | 4.63% |